AlzeCure Pharma
22.9.2021 14:20:11 CEST | ACCESS Newswire | Press release
STOCKHOLM, SE / ACCESSWIRE / September 22, 2021 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6)
AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops a broad portfolio of drug candidates for diseases affecting the central nervous system, with projects in both Alzheimer's disease and pain, today announced that the company is participating at the Naventus Life Science Summit at Grand Hotel in Stockholm on September 29 at 09:25 CEST, where CEO Martin Jönsson will present the company's latest developments.
The event is organized by Naventus Corporate Finance together with Setterwalls, Deloitte, FNCA, Nordnet and Nasdaq.
The presentation will be held in English and live streamed via https://events.naventus.com/ . The presentation will also be available after on AlzeCure's website https://www.alzecurepharma.se/en/presentations-and-interviews/ .
For more information, please contact
Martin Jönsson, CEO
Tel: +46 707 86 94 43
martin.jonsson@alzecurepharma.com
About AlzeCure Pharma AB (publ)
AlzeCure® is a Swedish pharmaceutical company that develops new innovative drug therapies for the treatment of severe diseases and conditions that affect the central nervous system, such as Alzheimer's disease and pain - indications for which currently available treatment is very limited. The company is listed on Nasdaq First North Premier Growth Market and is developing several parallel drug candidates based on three research platforms: NeuroRestore®, Alzstatin® and Painless.
NeuroRestore consists of two symptomatic drug candidates where the unique mechanism of action allows for multiple indications, including Alzheimer's disease, as well as cognitive disorders associated with traumatic brain injury, sleep apnea and Parkinson's disease. The Alzstatin platform focuses on developing disease-modifying and preventive drug candidates for early treatment of Alzheimer's disease and comprises two drug candidates. Painless is the company's research platform in the field of pain and contains two projects: ACD440, which is a drug candidate in the clinical development phase for the treatment of neuropathic pain, and TrkA-NAM, which targets severe pain in conditions such as osteoarthritis. AlzeCure aims to pursue its own projects through preclinical research and development to an early clinical phase, and is continually working on business development to find suitable outlicensing solutions with other pharmaceutical companies.
FNCA Sweden AB, +46(0)8 528 00 399 info@fnca.se , is the company's Certified Adviser. For more information, please visit www.alzecurepharma.se .
Attachments
AlzeCure presents at Naventus Life Science Summit on September 29
SOURCE: AlzeCure Pharma
View source version on accesswire.com:
https://www.accesswire.com/665112/AlzeCure-Presents-at-Naventus-Life-Science-Summit-on-September-29
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Side-by-Side Conference Hosts Close to 800 Participants in Malta to Advance Women's Health Care2.4.2026 14:10:00 CEST | Press release
Gedeon Richter's Side-by-Side Conference on Advancing Women's Health brought together Healthcare practitioners from 40 countries for a dynamic two-day exchange on March 26-27, making it the largest event of its kind ever organized by the company. BUDAPEST, HU / ACCESS Newswire / April 2, 2026 / Developed in collaboration with internationally recognized experts and grounded in peer-reviewed data, the program provided evidence-based updates on recent advances and innovations across key therapeutic areas, underscoring scientific integrity and evidence-based discussions. Beyond the science, the conference brought into focus how effective communication between healthcare professionals and patients can lead to improved diagnostic accuracy, treatment adherence, and overall patient satisfaction, as emphasized during his keynote lecture by Sukhbir Sony Singh, Full Professor and Chair of the Department of Obstetrics and Gynecology at the University of Ottawa. Day 1 focused on endometriosis and u
U.S. Polo Assn. Supports Division I National Intercollegiate Championship, Showcasing the Future of the Sport of Polo2.4.2026 13:00:00 CEST | Press release
DI Women's and Men's Finals to be Featured in ‘Breakaway: Polo in College' on ESPN WEST PALM BEACH, FLA. / ACCESS Newswire / April 2, 2026 / U.S. Polo Assn., the official sports brand of the United States Polo Association (USPA), proudly supported the Division I National Intercollegiate Championship (NIC), held March 19-22, 2026, near Dallas, Texas, at the Prestonwood Polo & Country Club. As the highest level of collegiate polo in the United States, the NIC brings together the nation's top student-athletes to compete for national titles.2026 Division I Women's National Intercollegiate Champions, University of South Carolina - Aiken Polo Team Winifred Branscum, Madison Jordan, and Brianna Jordan; 2026 Division I Men's National Intercollegiate Champions, University of North Texas Polo Team Alec Felhaber, Niklaus Felhaber, Johann Felhaber, Mosiah Gravesande, Sebastian Celis Guerrero Photo Credit: @oanaphoto As a proud supporter of the USPA's Intercollegiate/Interscholastic (I/I) Program,
Datavault AI Inc. (NASDAQ: DVLT) and Demora Foundation Execute Technology Integration Agreement to Power the K-Entertainment & K-Wave Global Platform1.4.2026 17:50:00 CEST | Press release
DVLT × Demora Foundation: Datavault AI's Enterprise AI Stack Deployed as the Data Intelligence & RWA Tokenization Layer for K-Pop, K-Drama, K-Entertainment, and K-Culture IP - Serving 200M+ Hallyu Fans Across 156 Countries Through K2Global's 500+ Korean SMB Network and Three US Innovation K-Wave Cities PHILADELPHIA, PA AND WILMINGTON, DE / ACCESS Newswire / April 1, 2026 / Datavault AI Inc. (NASDAQ:DVLT), an AI-driven data monetization, RWA tokenization, and Web 3.0 infrastructure company, and Demora Foundation, the Delaware-incorporated governing organization of the Demora Chain ecosystem (governed under JP3E Holdings Inc.), today announced the execution of a Technology Integration Agreement establishing Datavault AI as the formal AI data intelligence and RWA tokenization technology partner for the K-Entertainment & K-Wave Global Platform - the integrated K2Global + Demora Foundation ecosystem that converts Korean cultural IP, live entertainment, and K-Wave soft power into institution
Stagwell Announces UNICEPTA UK and Hootsuite Strategic Partnership to Deliver Decision-Grade Media Intelligence Within the Talkwalker Platform1.4.2026 17:00:00 CEST | Press release
Bringing together advanced technology and social insights to provide enterprise-ready, decision-grade media intelligence. LONDON, GB / ACCESS Newswire / April 1, 2026 / Stagwell (NASDAQ:STGW), the global challenger network transforming marketing through AI, today announced a strategic partnership between UNICEPTA, Stagwell's global provider of human-led, AI-fed media intelligence, and Hootsuite for their UK business. The collaboration integrates UNICEPTA UK's specialist media intelligence services into Hootsuite's Talkwalker platform environment, strengthening the intelligence capabilities available to communications leaders operating in complex, high-stakes environments. "Many FTSE 100 organisations already trust the combined UNICEPTA and Talkwalker solution. Our partnership with Hootsuite builds on that foundation - bringing together enterprise-level social intelligence with UNICEPTA's global content platform and managed services to deliver faster, more consistent and more actionable
Karbon-X Named Official Sustainability Partner of the Detroit Red Wings and Detroit Tigers1.4.2026 15:00:00 CEST | Press release
Multi-year partnership introduces verified environmental reporting and new fan-driven climate action across Little Caesars Arena and Comerica Park. CALGARY, AB / ACCESS Newswire / April 1, 2026 / Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or "the Company") today announced a multi-year sustainability partnership with the Detroit Red Wings and Detroit Tigers, establishing Karbon-X as the Official Sustainability Partner across both teams through Ilitch Sports + Entertainment. The collaboration brings verified climate action to two of Detroit's most celebrated franchises, supporting long-term environmental strategy at Little Caesars Arena and Comerica Park, and introducing new ways for fans to participate in meaningful sustainability efforts. As part of the partnership, Karbon-X will deliver independent, third-party greenhouse gas reporting for both organizations. These insights will support future planning and help identify opportunities to strengthen environmental performance across venue o
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom